Categories: News

Sacha Obaid, M.D. Named to Prestigious 2023 Texas Super Doctors List

Selection involves peer nominations, detailed independent research and a comprehensive Blue Ribbon Panel review of all candidates

SOUTHLAKE, TX / ACCESSWIRE / December 8, 2023 / Sacha Obaid, M.D., founder of North Texas Plastic Surgery, has been recognized as one of the top doctors in the state of Texas by the esteemed Texas Super Doctors® for the year 2023. This recognition, awarded to only approximately five percent of the region’s active physicians, reflects Dr. Obaid’s exceptional dedication and innovation in the field of plastic surgery.

The Texas Super Doctors selection process is renowned for its meticulousness, involving peer nominations, detailed independent research, and a comprehensive Blue Ribbon Panel review of all nominated candidates. Dr. Obaid’s inclusion in this elite group is a testament to his outstanding professional achievements and a high degree of peer recognition.

MSP Communications, based in Minneapolis, Minnesota, oversees the rigorous selection process. Candidates go through an evaluation, including surveys of doctors, independent research by the MSP research staff, peer reviews by practice area, and a good-standing check.

A distinguished plastic surgeon, Dr. Obaid’s journey to excellence began with his training in craniofacial surgery at the New York University Institute of Reconstructive Plastic Surgery. His commitment to understanding the intricacies of facial reconstruction led him to the prestigious Harvard Medical School, where he excelled in both academic and clinical pursuits.

Dr. Obaid’s skills in reconstructing and rejuvenating the face and body, coupled with his unique training from Harvard, UT Southwestern, and NYU, have positioned him as a leading expert in his field. His dedication to advancing plastic surgery is further evidenced by his research contributions, including leadership in breast reconstruction research published in the esteemed Plastic and Reconstructive Surgery journal.

In addition to the print publication in the December 23 issue of Texas Monthly, with an audience of over 2.5 million readers, the list of Texas Super Doctors will be available on the Super Doctors website (www.superdoctors.com).

For more information about Dr. Obaid and North Texas Plastic Surgery, please visit www.northtexasplasticsurgery.com.

###

About North Texas Plastic Surgery

North Texas Plastic Surgery is a renowned plastic surgery practice that delivers personalized, high-quality care to patients seeking aesthetic and reconstructive procedures. Led by a team of board-certified and board-eligible plastic surgeons, the practice offers a comprehensive range of services designed to enhance appearances and improve self-confidence. North Texas Plastic Surgery offers services across multiple towns in North Texas with the practice areas of body contouring, breast surgery, facial surgery, procedures for men, and Med Spa services.

For more information, please contact:

Dr. Sacha Obaid
North Texas Plastic Surgery
(214) 550-3240
https://www.northtexasplasticsurgery.com/
Instagram: https://www.instagram.com/realdoctoro/
Facebook: https://www.facebook.com/therealdoctoro
YouTube: https://www.youtube.com/channel/UCBUW2ncZpa57mNvN9bFTNNw/videos

SOURCE: North Texas Plastic Surgery

View the original press release on accesswire.com

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

2 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

3 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

3 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

4 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

6 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

6 hours ago